ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · IEX Real-Time Price · USD
6.18
-0.09 (-1.44%)
Jul 2, 2024, 4:00 PM EDT - Market closed
ImmunityBio Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ImmunityBio stock has a target of 6.00, which predicts a decrease of -2.91% from the current stock price of 6.18.
Analyst Consensus: Hold
* Price targets were last updated on Apr 29, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ImmunityBio is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | -2.91% | Apr 29, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | -19.09% | Mar 25, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $10 → $4 | Buy → Hold | Downgrades | $10 → $4 | -35.28% | May 12, 2023 |
| Jefferies | Jefferies | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +29.45% | Aug 3, 2022 |
Financial Forecast
Revenue This Year
72.99M
from 622.00K
Increased by 11,634.08%
Revenue Next Year
282.93M
from 72.99M
Increased by 287.65%
EPS This Year
-0.76
from -1.15
EPS Next Year
-0.53
from -0.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 113.2M | 323.6M | 551.1M |
| Avg | 73.0M | 282.9M | 531.7M |
| Low | 34.6M | 241.6M | 507.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 18,097.7% | 343.4% | 94.8% |
| Avg | 11,634.1% | 287.6% | 87.9% |
| Low | 5,463.3% | 231.1% | 79.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.68 | -0.44 | 0.03 |
| Avg | -0.76 | -0.53 | -0.16 |
| Low | -0.82 | -0.61 | -0.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.